全文获取类型
收费全文 | 7089篇 |
免费 | 454篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 180篇 |
儿科学 | 427篇 |
妇产科学 | 78篇 |
基础医学 | 744篇 |
口腔科学 | 108篇 |
临床医学 | 573篇 |
内科学 | 1677篇 |
皮肤病学 | 151篇 |
神经病学 | 491篇 |
特种医学 | 235篇 |
外科学 | 1241篇 |
综合类 | 68篇 |
一般理论 | 2篇 |
预防医学 | 489篇 |
眼科学 | 151篇 |
药学 | 448篇 |
中国医学 | 7篇 |
肿瘤学 | 495篇 |
出版年
2023年 | 48篇 |
2022年 | 103篇 |
2021年 | 274篇 |
2020年 | 145篇 |
2019年 | 229篇 |
2018年 | 284篇 |
2017年 | 226篇 |
2016年 | 226篇 |
2015年 | 258篇 |
2014年 | 375篇 |
2013年 | 415篇 |
2012年 | 571篇 |
2011年 | 589篇 |
2010年 | 306篇 |
2009年 | 248篇 |
2008年 | 432篇 |
2007年 | 409篇 |
2006年 | 374篇 |
2005年 | 296篇 |
2004年 | 285篇 |
2003年 | 277篇 |
2002年 | 214篇 |
2001年 | 72篇 |
2000年 | 66篇 |
1999年 | 70篇 |
1998年 | 49篇 |
1997年 | 47篇 |
1996年 | 48篇 |
1995年 | 34篇 |
1994年 | 26篇 |
1993年 | 23篇 |
1992年 | 35篇 |
1991年 | 31篇 |
1990年 | 32篇 |
1989年 | 27篇 |
1988年 | 38篇 |
1987年 | 27篇 |
1986年 | 32篇 |
1985年 | 30篇 |
1984年 | 19篇 |
1983年 | 23篇 |
1982年 | 24篇 |
1981年 | 23篇 |
1980年 | 16篇 |
1979年 | 18篇 |
1978年 | 14篇 |
1977年 | 17篇 |
1976年 | 14篇 |
1973年 | 16篇 |
1972年 | 18篇 |
排序方式: 共有7565条查询结果,搜索用时 15 毫秒
71.
Stephan Mielke Alex Sparreboom Seth M Steinberg Hans Gelderblom Clemens Unger Dirk Behringer Klaus Mross 《Clinical cancer research》2005,11(13):4843-4850
PURPOSE: The shortening of infusion time from 3 to 1 hour decreases the systemic exposure (area under the curve, AUC) of total and unbound paclitaxel but increases the AUC of its vehicle Cremophor EL, whereas the time above total paclitaxel concentrations of 0.05 micromol/L (T >0.05) remains almost constant. As both Cremophor EL and paclitaxel are neurotoxic, we evaluated their pharmacodynamic effects on the development of peripheral neuropathy as the most important nonhematologic toxicity. EXPERIMENTAL DESIGN: Patients with advanced cancer of different origin were randomized to receive a maximum of 12 weekly-given 1- or 3-hour infusions of 100 mg/m2 paclitaxel (Taxol). Twenty-four patients were assessable for both pharmacokinetics and peripheral neuropathy development evaluated by a clinical scoring system including sensory symptoms, strength, tendon reflexes, and vibratory sense. RESULTS: Patients with peripheral neuropathy development (n=14) received more weeks of therapy (P=0.056) and showed significantly higher T(>0.05) (P=0.022) and overall systemic drug exposures (weeks of therapy x AUC) for total paclitaxel (P=0.002) and unbound paclitaxel (P=0.003) than those without peripheral neuropathy. In Kaplan-Meier analyses, T(>0.05) > or = 10.6 hours (P=0.023), AUC of total paclitaxel > or = 4.7 microg/mL x hour (P = 0.047), and AUC of unbound paclitaxel > or = 0.375 microg/mL x hour (P = 0.095) were identified as being potential factors for peripheral neuropathy development. In a Cox regression analysis, only T(>0.05) > or = 10.6 hours remained as an independent risk factor (relative risk, 18.43; P = 0.036) after adjusting for prior vincamycin (relative risk, 11.28; P = 0.038). CONCLUSIONS: From the results obtained in this study, it is concluded that exposure to paclitaxel but not Cremophor EL is associated with peripheral neuropathy development. 相似文献
72.
Complement activation plays an important role in the pathogenesis of atypical hemolytic uremic syndrome. Eculizumab is a monoclonal antibody that blocks complement activity and has been approved for use in the treatment of atypical hemolytic uremic syndrome (HUS). Less well appreciated is the role of complement in Shiga toxin‐induced HUS (Shiga toxin producing Escherichia coli [STEC]‐HUS). To a limited extent, eculizumab has been used off label in patients with severe STEC‐HUS with neurological involvement. Through a systematic search of available databases, we identified 16 reports describing the use of eculizumab in STEC‐HUS (eight case reports/series, seven retrospective studies, and one prospective cohort study). All studies described its use in severe STEC‐HUS with neurological or multiorgan dysfunction; none were randomized or blinded. Four studies used the control groups. Although the overall quality of evidence is low, some published studies showed positive clinical improvement after treatment with eculizumab in severe STEC‐HUS with progressive neurological involvement. 相似文献
73.
74.
75.
Prabhu Manivannan Ankur Ahuja Hara Prasad Pati 《Indian journal of hematology & blood transfusion》2017,33(4):453-462
Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired clonal hematopoietic stem cell disorder with its protean clinical manifestations. This is due to partial or complete absence of ‘glycophosphatidyl-inositol-anchor proteins’ (GPI-AP). The main aim of this review is to highlight various diagnostic modalities available, basic principle of each test and recent advances in the diagnosis of PNH. Recently among various tests available, the flow cytometry has become ‘the gold standard’ for PNH testing. In order to overcome the difficulties encountered by the testing and research laboratories throughout the world, International Clinical Cytometry Society has come up with guidelines regarding the indications for testing, protocol for sample collection, processing, panel of antibodies as well as gating strategies to be used, how to interpret the test and reporting format to be used. It is essential to test at least two GPI-linked markers on at least two different lineages particularly on red cells and granulocytes/monocytes. The fluorescent aerolysin combined with other monoclonal antibodies in multicolour flow cytometry offered an improved assay not only for diagnosis but also for monitoring of PNH clones. It is equally important to diagnose this rare entity with high index of suspicion. 相似文献
76.
Pleomorphic liposarcoma (PLPS) is a rare, high‐grade sarcoma defined by the presence of pleomorphic lipoblasts. Constituting 5% of all liposarcomas, PLPS usually arises in deep soft tissues of the extremities, with rare occurrences in the dermis and subcutis. We describe a unique case of an 85‐year‐old Caucasian gentleman with a 1 year history of a pedunculated, pink, non‐tender papule on the dorsum of his left arm, measuring 1.0 cm in maximum dimension. Biopsy revealed a dermal collection of atypical epithelioid and spindle cells superimposed on a sclerotic background, resembling a pleomorphic fibroma on low power. On high power, a central focus of discrete adipocytic differentiation with pleomorphic lipoblasts was present. Tumor cells were positive for S‐100 and negative for desmin, actin, CD68, keratin, MART‐1 and CD34. Clinicopathologic findings were consistent with PLPS and the diagnosis was made. PLPS is rarely localized to the dermis and one with low power features resembling a pleomorphic fibroma has not been previously described in the literature. 相似文献
77.
78.
79.
Carrie Heincelman Seth Brown Eric England Kaushal Mehta Robert D. Wissman 《Skeletal radiology》2014,43(9):1297-1299
Rib stress injuries are uncommonly reported but have been documented among athletes, most notably rowers. There have only been two prior case reports of rib stress injuries in swimmers, both of which were young females. Magnetic resonance (MR) imaging was either not obtained or the imaging characteristics were incompletely described. We present a case of an isolated third rib stress injury in a collegiate male swimmer diagnosed via MR imaging. We briefly discuss the possible etiologies for rib stress injuries, their MR appearance, as well as their treatment. 相似文献
80.